Live Breaking News & Updates on Biogen Inc

Stay updated with breaking news from Biogen inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S.. ....

United States , Thomasw Elrod , Christophera Viehbacher , Biogen Inc , Us District Court , Kirby Mcinerney , Class Period , Reata Acquisition , New York Based , Attorney Advertising ,

Shareholders that lost money on Biogen Inc.(BIIB) Urged to Join Class ...

Shareholders that lost money on Biogen Inc.(BIIB) Urged to Join Class ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United States , Llpjosephe Levi , Josephe Levi , Ed Korsinsky , Levi Korsinsky , Biogen Inc , Securities Class Action Service Top , News Network , Reata Acquisition , Class Action Service Top , Esq Ed Korsinsky , Floornew York ,

BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors ...

BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United States , Ed Korsinsky , Josephe Levi , Llpjosephe Levi , Levi Korsinsky , News Network , Securities Class Action Service Top , Biogen Inc , Reata Acquisition , Class Action Service Top , Esq Ed Korsinsky , Floornew York ,

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , United Kingdom , Saudi Arabia , Hong Kong , Great Britain , Julie Edelman , Haruo Naito , Christophera Viehbacher , Tsujim Protofibrils , Jack Cox , Chuck Triano , Alzheimer Clinical Trial Consortium , Public Relations Department , Communications Department , National Institutes Of Health , Eisai Co Ltd , Investor Relations Department , Washington University School Of Medicine , Exchange Commission , National Institute On , United Nations Sustainable Development Goals Sdgs , Alzheimer Network Trials Unit , Eisai Inc , Eisai Europe Ltd , European Union ,

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb)

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb)
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , United Kingdom , Saudi Arabia , South Korea , Great Britain , Julie Edelman , Jack Cox , Christophera Viehbacher , Chuck Triano , Tsujim Protofibrils , Haruo Naito , United Nations Sustainable Development Goals Sdgs , Eisai Europe Ltd , National Institutes Of Health , Biogen Inc , Exchange Commission , European Union , Drug Administration , Communications Department , Washington University School Of Medicine , National Institute On , Investor Relations Department , Public Relations Department , Alzheimer Clinical Trial Consortium , Eisai Co Ltd ,